Commentary| Volume 88, ISSUE 9, P670-672, November 01, 2020

Challenges Associated With Neuropharmacological Challenge Studies

  • Daniel H. Mathalon
    Address correspondence to Daniel H. Mathalon, M.D., Ph.D.
    San Francisco Veterans Affairs Health Care System and the Department of Psychiatry and Behavioral Sciences, Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, California
    Search for articles by this author
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Strube W.
        • Marshall L.
        • Quattrocchi G.
        • Little S.
        • Cimpianu C.L.
        • Ulbrich M.
        • et al.
        Glutamatergic contribution to probabilistic reasoning and jumping to conclusions in schizophrenia: A double-blind, randomized experimental trial.
        Biol Psychiatry. 2020; 88: 687-697
        • Falcone M.A.
        • Murray R.M.
        • Wiffen B.D.
        • O’Connor J.A.
        • Russo M.
        • Kolliakou A.
        • et al.
        Jumping to conclusions, neuropsychological functioning, and delusional beliefs in first episode psychosis.
        Schizophr Bull. 2015; 41: 411-418
        • Moritz S.
        • Woodward T.S.
        The contribution of metamemory deficits to schizophrenia.
        J Abnorm Psychol. 2006; 115: 15-25
        • Ross R.M.
        • McKay R.
        • Coltheart M.
        • Langdon R.
        Jumping to conclusions about the beads task? A meta-analysis of delusional ideation and data-gathering.
        Schizophr Bull. 2015; 41: 1183-1191
        • Umbricht D.
        • Koller R.
        • Vollenweider F.X.
        • Schmid L.
        Mismatch negativity predicts psychotic experiences induced by NMDA receptor antagonist in healthy volunteers.
        Biol Psychiatry. 2002; 51: 400-406
        • Cortes-Briones J.
        • Skosnik P.D.
        • Mathalon D.
        • Cahill J.
        • Pittman B.
        • Williams A.
        • et al.
        Delta9-THC disrupts gamma (gamma)-band neural oscillations in humans.
        Neuropsychopharmacology. 2015; 40: 2124-2134
        • Mattay V.S.
        • Goldberg T.E.
        • Fera F.
        • Hariri A.R.
        • Tessitore A.
        • Egan M.F.
        • et al.
        Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine.
        Proc Natl Acad Sci U S A. 2003; 100: 6186-6191
        • Vijayraghavan S.
        • Wang M.
        • Birnbaum S.G.
        • Williams G.V.
        • Arnsten A.F.
        Inverted-U dopamine D1 receptor actions on prefrontal neurons engaged in working memory.
        Nat Neurosci. 2007; 10: 376-384
        • Mehta M.A.
        • Owen A.M.
        • Sahakian B.J.
        • Mavaddat N.
        • Pickard J.D.
        • Robbins T.W.
        Methylphenidate enhances working memory by modulating discrete frontal and parietal lobe regions in the human brain.
        J Neurosci. 2000; 20: RC65
        • Chen J.
        • Lipska B.K.
        • Halim N.
        • Ma Q.D.
        • Matsumoto M.
        • Melhem S.
        • et al.
        Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): Effects on mRNA, protein, and enzyme activity in postmortem human brain.
        Am J Hum Genet. 2004; 75: 807-821

      Linked Article